Filing Flows › Silicon Laboratories (SLAB) › Q1 2026 › vs Q4 2025
Silicon Laboratories (SLAB) Q1 2026 vs Q4 2025 (quarter over quarter)
Silicon Laboratories's revenue rose $5.3M (+3%) from $208M in Q4 2025 to $214M in Q1 2026.
Silicon Laboratories, Q1 2026: revenue $214M (+20% year over year), operating margin -8.0%, net loss $15.9M, operating cash flow $4.9M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $214M | $208M | $5.3M | +3% |
| Other income, net | $3.4M | $2.7M | $676K | +25% |
| Net loss | $15.9M | $2.7M | $13.2M | +492% |
| Costs & expenses | $233M | $214M | $19.2M | +9% |
| Operating costs | $231M | $211M | $19.1M | +9% |
| Income tax | $2.2M | $2.1M | $59K | +3% |
| Cost of revenue | $86.5M | $76.1M | $10.4M | +14% |
| Research & development | $88.6M | $89.5M | −$927K | -1% |
| SG&A | $55.5M | $45.8M | $9.7M | +21% |
| Operating cash sources | $27.1M | $40.0M | −$12.9M | -32% |
| Depreciation | $6.0M | $19.3M | −$13.3M | -69% |
| Share-based compensation | $21.1M | $20.7M | $376K | +2% |
| Net loss absorbed | $15.9M | $2.7M | $13.2M | +492% |
| Working capital & other | $6.3M | $29.0M | −$22.7M | -78% |
| Operating cash flow | $4.9M | $8.3M | −$3.4M | -41% |
| Capital expenditures | $9.8M | $10.0M | −$143K | -1% |
| Negative free cash flow (OCF − capex) | $4.9M | $1.6M | $3.3M | +201% |
Questions
How much did Silicon Laboratories's revenue grow quarter over quarter in Q1 2026?
Silicon Laboratories's revenue rose $5.3M (+3%) from $208M in Q4 2025 to $214M in Q1 2026.